Pulmonary cryptococcosis misdiagnosed as smear-negative pulmonary tuberculosis with fatal consequences  by Jarvis, Joseph N. et al.
International Journal of Infectious Diseases 14S (2010) e310–e312Case Report
Pulmonary cryptococcosis misdiagnosed as smear-negative pulmonary
tuberculosis with fatal consequences
Joseph N. Jarvis a,b,c,d,*, Helen Wainwright e, Thomas S. Harrison c, Kevin Rebe a,b, Graeme Meintjes a,b
a Infectious Diseases Unit, GF Jooste Hospital, Cape Town, South Africa
bDivision of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, South Africa
cCentre for Infection, Department of Cellular and Molecular Medicine, St. George’s, University of London, London, UK
dDesmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
eDivision of Anatomical Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
A R T I C L E I N F O
Article history:
Received 27 July 2009
Received in revised form 14 October 2009
Accepted 25 February 2010
Corresponding Editor: William Cameron,
Ottawa, Canada
Keywords:
Cryptococcosis
Cryptococcal meningitis
Pulmonary
Tuberculosis
HIV
Africa
S U M M A R Y
HIV-associated pulmonary cryptococcosis is under diagnosed, and may progress to fatal meningoen-
cephalitis. We present a case of HIV-associated pulmonary Cryptococcus neoformans infection, initially
mis-diagnosed as smear-negative pulmonary TB, which progressed to fatal cryptococcal meningitis.
Autopsy series suggest that pulmonary cryptococcosis is common in African AIDS patients, and, due to
limited diagnostic capacity, often mis-diagnosed as smear negative TB. Serum cryptococcal antigen
testing may facilitate diagnosis in such cases.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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HIV-associated pulmonary disease due to Cryptococcus neofor-
mans is less frequently reported than cryptococcal meningitis, but
is likely underdiagnosed. Without appropriate treatment severe
pulmonary manifestations and progression to meningoencephali-
tis may occur, both with highmortality.1,2 We present the case of a
patient with pulmonary cryptococcosis, initially misdiagnosed as
smear-negative pulmonary tuberculosis, who later developed
extensive lung disease and fatal cryptococcalmeningoencephalitis.
2. Case report
A 27-year-old African female was admitted to the medical
ward with a 3-week history of cough, dyspnea, pleuritic chest
pain, fever, and night sweats. She was not complaining of
headache, and a neurological assessment was unremarkable.
She had ﬁnished a standard 6-month course of anti-tuberculous
therapy for culture-proven pulmonary tuberculosis 8 days* Corresponding author. Tel.: +27 (0)21 650 6987; fax: +27 (0)21 650 6963.
E-mail address: joejarvis@doctors.net.uk (J.N. Jarvis).
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doi:10.1016/j.ijid.2010.02.2255previously. A chest X-ray (CXR) showed bilateral diffuse nodular
inﬁltrates with multiple cavities (Figure 1A). Sputummicroscopy
was negative for acid-fast bacilli andHIV testingwas positive. Her
CD4 count was 27 cells/ml. There was no response to amoxicillin
prescribed to cover community-acquired pneumonia, and a
diagnosis of smear-negative pulmonary tuberculosis was made
using the World Health Organization (WHO) algorithm for the
diagnosis of TB in resource-constrained, HIV-prevalent settings.3
The patient was commenced on standard anti-TB therapy, and
discharged with a plan to commence antiretroviral therapy
following 4 weeks of treatment. Sputum was sent for TB culture
and drug susceptibility testing in view of concerns about drug-
resistant TB, given recent completion of anti-TB therapy; however
cultures were negative.
Nineteen days later the patient presented again following three
grand mal seizures. She had a 3-day history of headache and
confusion, and a productive cough since discharge. There was
marked neck stiffness and two molluscum-like lesions typical of
cutaneous cryptococcosis on her face. A repeat CXR showed more
extensive inﬁltrates (Figure 1B). India ink staining of the
cerebrospinal ﬂuid revealed numerous encapsulated yeasts and
C. neoformans was subsequently cultured. Amphotericin B-based
therapy for cryptococcal meningitis was started along withses. Published by Elsevier Ltd. All rights reserved.
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Figure 1. (A) Initial chest X-ray showing diffuse bilateral nodular inﬁltrates with multiple cavities. (B) Repeat chest X-ray showing more extensive inﬁltrates, with increased
right lower zone opaciﬁcation. (C) Cut section of the right lung showing an apical cavity and multiple foci of consolidation with a mucoid appearance. (D) Distended alveoli
ﬁlled with cryptococci, indicated by arrows (40 magniﬁcation, hematoxylin–eosin stain).
J.N. Jarvis et al. / International Journal of Infectious Diseases 14S (2010) e310–e312 e311phenytoin, but the patient’s neurological condition worsened and
she died on the second day of admission.
Post-mortem studies revealed basal meningitis and crypto-
coccomas in the right caudate lobe and cerebellum,with numerous
cryptococci within the meninges. A cut section of the right lung
showed an apical cavity and multiple foci of consolidation with
mucoid appearance (Figure 1C). Histologically these lesions
consisted of massively distended alveoli ﬁlled with cryptococci
(Figure 1D), with numerous cryptococcal organisms also seen in
the dilated lymphatics, submucosa, and peri-bronchial tissue.
There was no inﬂammatory response to the cryptococci, and no
evidence of pulmonary tuberculosis.
3. Discussion
Pulmonary involvement in patients with HIV-associated
cryptococcal meningitis is reported in up to 55% of cases,1 and
symptoms may precede the onset of meningoencephalitis,4
suggesting diagnosis prior to neurological involvement may be
possible. In many areas of high HIV prevalence, diagnostic capacity
is limited, meaning pulmonary cryptococcosis is rarely diagnosed.
In the few studies that have used bronchoscopy or induced sputum
investigation in AIDS patients with respiratory symptoms,
pulmonary cryptococcosis is relatively common,5,6 and is a
frequent ﬁnding in autopsy series of AIDS deaths in Africa. An
autopsy series of 8421 South African miners, with an estimated
HIV prevalence of 24%, identiﬁed 589 cases of pulmonarycryptococcosis (overall prevalence of 7%). Ante-mortem 46.9% of
these cases had a diagnosis of cryptococcal meningitis, and 1.2%
had been diagnosed with pulmonary cryptococcosis. The remain-
ing 51.9% of cases had frequently beenmisdiagnosed as pulmonary
tuberculosis.7 Further evidence that suggests pulmonary crypto-
coccosis is often empirically treated as pulmonary tuberculosis is
the ﬁnding that the commonest cause of late mortality at autopsy
in a large African cohort on treatment for TBwas cryptococcosism,8
and that cryptococcal infection has been shown to be a common
cause for clinical deterioration in those taking anti-tuberculous
therapy in our setting.9
Our experience in a public sector referral hospital in South
Africa, where 37% of patients presenting with cryptococcal
meningitis have pulmonary symptoms and 15% have been
diagnosed with smear-negative TB in the 3 months preceding
admission with cryptococcal meningitis, suggests the diagnosis of
pulmonary cryptococcosis is frequently overlooked or attributed to
tuberculosis, leading in many cases to the development of
cryptococcal meningoencephalitis (unpublished data). While
bronchoscopy, induced sputum examination, or fungal sputum
cultures are not readily accessible in resource-limited settings,
existing highly sensitive and speciﬁc cryptococcal antigen detec-
tion (CRAG) tests for use on serum10,11 could easily be made
available. We advocate serum CRAG screening as part of the
diagnostic work-up of patients with suspected smear-negative
pulmonary TB. The WHO smear-negative algorithm3 facilitates
earlier diagnosis of TB in HIV-infected patients. However, this case
J.N. Jarvis et al. / International Journal of Infectious Diseases 14S (2010) e310–e312e312highlights the potential shortcomings of making an empiric
diagnosis of TB, particularly in situations where guidelines may
not be so readily applied, such as following recent completion of
anti-tuberculous therapy. It is important to exclude alternative
diagnoses such as pulmonary cryptococcosis.
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